ARCHIVES

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

This article is from The Cancer Letter archive.

Vol. 26 No. 25 | June 23, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Kea, Montes Leave DCPC; Smart Heads Early Detection Branch; Costlow Special Assistant

October 3, 1986

ACS Asks Congress For $1.32 Billion NCI ’87 Budget

April 4, 1986

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data

March 18, 2011

2015 Goal Not a Dream, But a Vision, Director Says

July 18, 2003

Biology Societies Endorse Cloning Prohibition Act.

February 1, 2002